Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet- derived growth factor and transforming growth factor-β

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 533-546

  Evanko, Stephen P ^a   Raines, Elaine W ^a   Ross, Russell ^a   Gold, Leslie I ^b   Wight, Thomas N ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; DECORIN; HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VERSICAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; MACACA; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; ISOMERISM; MACACA NEMESTRINA; PLATELET-DERIVED GROWTH FACTOR; PROTEOGLYCANS; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031931072     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Wight TN: The vascular extracellular matrix. Atherosclerosis and Coronary Artery Disease. Edited by Fuster V, Ross R, Topol EJ. Philadelphia, Lippincott-Raven, 1996, pp 421-440
2. Nikkari S, Jarvelainen HT, Wight TN, Ferguson M, Clowes AW: Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 1994, 144:1348-1356
3. Wolf Y, Rasmussen LM, Ruoslahti E: Antibodies against transforming growth factor-β1 suppress intimai hyperplasia in a rat model. J Clin Invest 1994, 93:1172-1178
4. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN: Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994, 144:962-974
5. Riessen R, Wight TN, Pastore C, Henley C, Isner JM: Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996, 93:1141-1147
6. Faggiotto A, Ross R, Harker L: Studies of hypercholesterolemia in the non human primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984, 4:323-340
7. Yao L, Moody C, Schonherr E, Wight TN, Sandell LJ: Identification of the proteoglycan versican in aorta and SMCs by DNA sequence analysis, in situ hybridization, and immunohistochemistry. Matrix Biol 1994, 14:213-225
8. Brown DC, Vogel KG: Characteristics of the in vitro interaction of a small proteoglycan (PGII) of bovine tendon with type I collagen. Matrix 1989, 9:468-478
9. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H: Interaction of biglycan with type I collagen. J Biol Chem 1995, 270:2776-2783
10. Baccarani-Contri M, Vincenzi D, Cicchetti F, Mori G, Pasquali-Ronchetti I: Immunocytochemical localization of proteoglycans within normal elastin fibers. Eur J Cell Biol 1990, 53:305-312
11. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN: Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991, 266:17640-17647
12. Schonherr E, Jarvelainen HT, Kinsella MG, Sandell LJ, Wight TN: Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb 1993, 13:1026-1036
13. Papakonstantinou E, Karakiulakis G, Roth M, Block LH: Platelet derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci USA 1995, 92:9881-9885
14. Sambandam T, Baker JR, Christner JE, Ekborg SL: Specificity of low density lipoprotein-glycosaminoglycan interaction. Arterioscler Thromb 1991, 11:561-568
15. Cardoso L, Mourao PAS: Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 1994, 14:115-124
16. Chen JK, Hoshi H, McKeehan WL: Transforming growth factor β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Nat Acad Sci USA 1987, 84:5287-5291
17. Levine JH, Moses HL, Gold LI, Nanney LB: Spatial and temporal patterns of immunoreactive transforming growth factor β1, β2, and β3 during excisional wound repair. Am J Pathol 1993, 143:368-380
18. Frank S, Madlener M, Werner S: Transforming growth factor β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996, 271:10188-10193
19. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ: Transforming growth factors-β1, -β2, and -β3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997, 150:981-991
20. Majesky M, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 1991, 88:904-910
21. Bahadori L, Milder J, Gold L, Botney M: Active macrophage-associated TGF-β co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol 1995, 146: 1140-1149
22. Ross R, Masuda J, Rames EW, Gown AM, Katsuda S, Sasahara M, Maiden LT, Masuko, H, Sato, H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990, 248: 1009-1012
23. Volker W, Schmidt A, Oortman W, Broszey T, Faber V, Buddecke E: Mapping of proteoglycans in atherosclerotic lesions. Eur Heart J 1990, 11(suppl E):29-40
24. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG: Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990, 38:1549-1563
25. du Cros D, LeBaron RG, Couchman JR: Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J Invest Dermatol 1995, 105:426-431
26. Pierce G, Tarpley JE, Tseng J, Bready J, Chang D, Kenney WC, Ross R, Robson MC, Van de Berg J, Reid P, Kaufman S, Farrell CL: Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest 1995, 96:1336-1350
27. Pelton R, Saxena B, Jones M, Moses HL, Gold LI: Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991, 115:1091-1105
28. Underhill C, Nguyen H, Shizari M, Culty M: CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 1993, 155:324-336
29. Gown, AM, Tsukada T, Ross R: Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986, 125:191-207
30. Masuda J, Ross R: Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis 1990, 10:164-177
31. Masuda J, Ross R: Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1990, 10:178-187
32. Nunes I, Shapiro RL, Rifkin DB: Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol 1995, 155: 1450-1459
33. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743
34. Wainwright S, Biggs WD, Currey JD, Gosline JM: Mechanical Design in Organisms. Princeton, NJ, Princeton University Press, 1982, pp 124-127
35. Robbins R, Wagner WD, Register TC, Caterson B: Immunolocalization of proteoglycan types in aortas of pigeons with spontaneous or diet induced atherosclerosis. Am J Pathol 1989, 134:615-626
36. Lark M, YeoT-K, Mar H, Lara S, Hellstrom I, Hellstrom K-E, Wight TN: Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody. J Histochem Cytochem 1988, 36:1211-1221
37. Galis Z, Alaavi MZ, Moore S: In situ ultrastructural characterization of chondroitin sulfate proteoglycans in normal rabbit aorta. J Histochem Cytochem 1992, 40:251-263
38. Galis Z, Alaavi MZ, Moore S: Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis. Am J Pathol 1993, 142:1432-1438
39. LeBaron R, Zimmerman DR, Ruoslahti E: Hyaluronate binding properties of versican. J Biol Chem 1992, 267:10003-10010
40. Wight TN, Lara S, Reissen R, LeBaron R, Isner J: Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol 1997, 151:963-973
41. Savani R, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA: Migration of bovine aortic endothelial cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest 1995, 95:1158-1168
42. Brecht M, Mayer U, Schlosser E, Prehm P: Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986, 239:445-450
43. Lin H, Ignatescu M, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM: Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: geographic relationship to vessel wall proteoglycans. J Heart Lung Transplant 1996, 15:1223-1232
44. Halpert I, Sires UI, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC: Matrilysin is expressed by lipid laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 1996, 93 9748-9753
45. Perides G, Asher RA, Lark MW, Lane WS, Robinson RA, Bignami A: Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biochem J 1995, 312:377-384
46. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94: 2493-2503
47. Lohmander LS: The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis. J Rheumatol Suppl 1995, 43: 75-77
48. Lin H, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM: Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allografts: distinctness as compared to native atherosclerosis. J Heart Lung Transplant 1996, 15:1233-1247
49. Weiser M, Srieshaber NA, Schwartz PE, Majack RA: Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. Mol Biol Cell 1997, 8:999-1011
50. Van der Wal AC, Das PK, Tigges AJ, Becker AE: Macrophage differentiation in atherosclerosis: an in situ immunohistochemical analysis in humans. Am J Pathol 1992, 141:161-168
51. Kraiss LW, Raines EW, Wilcox JN, Seifert RA, Barrett TB, Kirkman TR, Hart CE, Bowen-Pope DP, Ross R, Clowes AW: Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest 1993, 92:338-348
52. Alpers CE, Davis CL, Barr D, Marsh CL, Hudkins KL: Identification of platelet-derived growth factor A- and B-chains in human renal vascular rejection. Am J Pathol 1996, 148:439-451
53. Merwin JR, Newman W, Beall LD, Tucker A, Madri J: Vascular cells respond differentially to transforming growth factors-β1 and -β2 in vitro. Am J Pathol 1991, 138:37-51
54. Khalil N, Corne S, Whitman C, Yacyshyn H: Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin-injury. Am J Respir Cell Mol Biol 1996, 15:252-259
55. Reilly KM, Melton DA: Short-range signaling by candidate morphogens of the TGFβ family and evidence for a relay mechanism of induction. Cell 1996, 86:743-754
56. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 1991, 64:867-869
57. DeLuca A, Manoranjan S, Baldi A, Giordano A, Iozzo, RV: Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996, 271: 18961-18965
58. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A: Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth-factor receptor binding, mitogenesis, and angiogenesis. Cell 1994, 79:1005-1013
59. Raines E, Ross R: Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded seguences. J Cell Biol 1992, 116:533-543
60. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border W, Ruoslahti E: Interaction of the small interstitial proteoglycans biglycan, decorin, and fibromodulin with transforming growth factor β. Biochem J 1994, 302:527-534
61. Border WA, Noble NA, Yamamoto T, Harper J, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992, 360:361-364
62. Scott P, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F: Immunohistochemical localization of the proteoglycans decorin, biglycan, and versican and transforming growth factor-β in human post-burn hypertrophic and mature scars. Histopathology 1995, 26:423-431